Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application

• Published in: Advances in biochemical engineering, biotechnology Vol. 163; p. 117
• Main Authors: Jara Avaca, Monica, Gruh, Ina
• Format: Journal Article
• Language: English
• Published: Germany 01.01.2018
• Subjects: Myocardial tissue; Cardiomyocytes; Pluripotent stem cells; Tissue engineering; Scaffolds
• ISSN: 0724-6145
• DOI: 10.1007/10_2017_24

Engineered cardiac tissue might enable novel therapeutic strategies for the human heart in a number of acquired and congenital diseases. With recent advances in stem cell technologies, namely the availability of pluripotent stem cells, the generation of potentially autologous tissue grafts has become a realistic option. Nevertheless, a number of limitations still have to be addressed before clinical application of engineered cardiac tissue based on human stem cells can be realized. We summarize current progress and pending challenges regarding the optimal cell source, cardiomyogenic lineage specification, purification, safety of genetic cell engineering, and genomic stability. Cardiac cells should be combined with clinical grade scaffold materials for generation of functional myocardial tissue in vitro. Scale-up to clinically relevant dimensions is mandatory, and tissue vascularization is most probably required both for preclinical in vivo testing in suitable large animal models and for clinical application. Graphical Abstract.